Please login to the form below

Not currently logged in
Email:
Password:

antibiotics

This page shows the latest antibiotics news and features for those working in and with pharma, biotech and healthcare.

Novo launches $165m antimicrobial resistance initiative

Novo launches $165m antimicrobial resistance initiative

Novo launches $165m antimicrobial resistance initiative. The REPAIR Fund will support groups looking to combat antibiotic resistance. ... According to Novo, more than 700, 000 people die each year from infections resistant to most or all antibiotics, and

Latest news

More from news
Approximately 52 fully matching, plus 295 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    No new classes of antibiotics have been introduced for more than 30 years and antibiotic patent applications worldwide. ... But PUSH incentives are not enough to fix the problem with the antibiotics market.

  • Health on instalment Health on instalment

    The only apt parallel might be the discovery of antibiotics or vaccines, but even those milestones may end up paling in comparison.

  • Significant figures Significant figures

    us.”. An inhaled formulation of last-resort antibiotic Amikacin, ALIS taps into a need for new antibiotics as well as industry heads towards more joined-up thinking to tackle antimicrobial resistance. ... European physicians welcome the development of

  • Here’s to all the bright sparks Here’s to all the bright sparks

    We pop to the doctors for a course of antibiotics, for example.

  • A rare talent A rare talent

    Unconventionally experienced. Sebastian joined Shire from Cubist, whose commercial operations for the UK, Ireland and Nordics he established to launch two novel antibiotics.

More from intelligence
Approximately 5 fully matching, plus 30 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Nabriva Therapeutics appoints new chief commercial officer. Francesco Maria Lavino joins to support commercialisation of its new antibiotic. ... He said: “Nabriva Therapeutics is poised to introduce what is potentially the first new class of

  • Destiny Pharma appoints new CEO Destiny Pharma appoints new CEO

    development. He said: “The resistance to antibiotics is becoming a global issue that needs to be addressed and I believe Destiny has a significant part to play.

  • Dr Engelbert Tjeenk Willink joins Allecra Therapeutics Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

    Regulatory authorities have recognised the potential that Allecra’s novel antibiotic may contribute towards solving the crisis of resistant bacterial infections, and out lead development programme has been significantly expedited. ... With these new

  • Micreos appoints chief medical officer Micreos appoints chief medical officer

    In his new role Dr Frieling will be responsible for overseeing Micreos' antibiotic alternative, Staphefekt, as it begins clinical trials.

  • Nabriva Therapeutics adds Will Sargent to team Nabriva Therapeutics adds Will Sargent to team

    He said: “ I am excited to join this talented and dedicated team focused on advancing a novel, targeted antibiotic therapy that can impact patients' lives by addressing an unmet medical need. “

More from appointments
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • How do you solve a problem like non-adherence? Part 1

    Lack of information around non-adherence can impact behaviour. For common prescriptions such as antibiotics, it has been assumed that the importance of adherence is recognised, so instructions may not be ... Even when a patient adheres to their treatment,

  • Our nursing heroes

    The patient had a persistent chest infection and her GP had prescribed more antibiotics and sent her for an X-ray.

  • Adelphi Research UK Welcomes Six New Starters

    She has carried out exchange programmes in China and Hong Kong and has also completed two research internships in novel antibiotic discovery.

  • Antibiotic Resistance: Alarm bells ring louder than ever

    where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... 1. Prevent the need for antibiotics.Immunisation programmes engender immunity and make people less susceptible to pathogens.

  • Virtual reality—a change for the better in medical education

    keeps insisting that her mother be prescribed antibiotics despite inconclusive evidence that antibiotics are necessary. ... The responses of medical general practitioners to unreasonable patient demand for antibiotics— a study of medical ethics using

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics